Status:

COMPLETED

Assessment of Serum Levels of Vitamin D, Vitamin B12 and Folic Acid Among Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Treatment.

Lead Sponsor:

Sohag University

Conditions:

Vitamin D, Vitamin B12 and Folic Acid Among Patients With Premature Ejaculation

Eligibility:

MALE

20-50 years

Phase:

NA

Brief Summary

Therefore, this study will aim to assess serum levels of vitamin D, vitamin B12 and folic acid among patients with lifelong PE and non-responding to dapoxetine treatment.

Detailed Description

We will consider the patients with LPE non-responding to dapoxetine treatment when they used the optimum dose (30 and 60mg) dapoxetine for 4 separate times with no response. Serum vitamin D, vitamin ...

Eligibility Criteria

Inclusion

  • premature ejaculation
  • non-responding to dapoxetine treatment.

Exclusion

  • diabetes mellitus,
  • chronic prostatitis,
  • Advanced renal or hepatic diseases
  • neurological diseases and
  • C.N.S. medications

Key Trial Info

Start Date :

February 28 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2020

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04355949

Start Date

February 28 2020

End Date

June 30 2020

Last Update

January 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Medicine, Sohag University, Egypt

Sohag, Egypt, 82524